Literature DB >> 10675866

Factors influencing stereoacuity in accommodative esotropia.

S Fawcett1, J Leffler, E E Birch.   

Abstract

PURPOSE: Despite successful optical realignment, many children with accommodative esotropia (ET) have abnormal stereoacuity. In a prospective study, we examined the influence of age of onset, age at alignment, duration of constant misalignment, and accommodative convergence/accommodation ratio on random dot stereoacuity outcomes in accommodative ET.
METHODS: Participants were 111 consecutive children with accommodative ET. Random dot stereoacuity was measured using the Randot preschool stereoacuity test, the Randot stereoacuity test, the infant random dot stereoacuity cards, and the Lang 1.
RESULTS: Age of onset has only a minor influence on stereoacuity (P <.02); children with onset >/=age 25 months have better stereoacuity compared with children with an onset between ages 7 and 17 months. Age at alignment has a minor influence on stereoacuity (P <.001); children with intermittent ET who have been treated have better stereoacuity than children with a constant ET aligned between ages 6 and 24 months and after age 24 months. Duration of constant misalignment has the strongest influence on stereoacuity (P <.001); children who had intermittent misalignment or who had a constant misalignment of less than 4 months' duration have better stereoacuity than patients who had a constant misalignment greater than 4 months' duration. The accommodative convergence/accommodation ratio does not influence stereoacuity outcomes (P >.10).
CONCLUSIONS: Fine random dot stereoacuity is associated with a constant misalignment of less than 4 months' duration. These findings promote prompt and aggressive treatment of accommodative ET at the onset of intermittent or constant misalignment.

Entities:  

Mesh:

Year:  2000        PMID: 10675866     DOI: 10.1016/s1091-8531(00)90006-5

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  14 in total

1.  The influence of refractive error management on the natural history and treatment outcome of accommodative esotropia (an American Ophthalmological Society thesis).

Authors:  Bradley Charles Black
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 2.  Stereo vision and strabismus.

Authors:  J C A Read
Journal:  Eye (Lond)       Date:  2014-12-05       Impact factor: 3.775

3.  Long-term study of accommodative esotropia.

Authors:  Irene H Ludwig; Susan P Imberman; Hilary W Thompson; Marshall M Parks
Journal:  Trans Am Ophthalmol Soc       Date:  2003

4.  A quantitative study of fixation stability in amblyopia.

Authors:  Vidhya Subramanian; Reed M Jost; Eileen E Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-19       Impact factor: 4.799

Review 5.  Amblyopia and binocular vision.

Authors:  Eileen E Birch
Journal:  Prog Retin Eye Res       Date:  2012-11-29       Impact factor: 21.198

Review 6.  Stereoacuity outcomes after treatment of infantile and accommodative esotropia.

Authors:  Eileen E Birch; Jingyun Wang
Journal:  Optom Vis Sci       Date:  2009-06       Impact factor: 1.973

7.  Congenitally Impaired Disparity Vergence in Children With Infantile Esotropia.

Authors:  Krista R Kelly; Joost Felius; Santoshi Ramachandran; Blesson A John; Reed M Jost; Eileen E Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799

Review 8.  Management of amblyopia in pediatric patients: Current insights.

Authors:  Sagnik Sen; Pallavi Singh; Rohit Saxena
Journal:  Eye (Lond)       Date:  2021-07-07       Impact factor: 3.775

9.  To evaluate stereoacuity in patients with acquired esotropia and to determine factors associated with favourable outcomes.

Authors:  Monisha E Nongpiur; Anirudh Singh; Rohit Saxena; Anudeepa Sharma; Pradeep Sharma
Journal:  Indian J Ophthalmol       Date:  2014-06       Impact factor: 1.848

10.  Long-term outcomes of prismatic correction in partially accommodative esotropia.

Authors:  Hye Rim Choe; Hee Kyung Yang; Jeong-Min Hwang
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.